| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | -6.9% |
| R&D Expense | $792K | +85.6% |
| SG&A Expense | $2.6M | +45.0% |
| Operating Income | -$3.4M | -97.9% |
| Net Income | -$3.4M | -167.4% |
| EPS (Basic) | -$0.40 | -122.2% |
| EPS (Diluted) | -$0.40 | -122.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.1M | +417.3% |
| Accounts Receivable | $86K | +125.0% |
| Current Assets | $5.3M | +415.3% |
| Total Assets | $6.7M | +399.9% |
| Current Liabilities | $675K | +229.5% |
| Total Liabilities | $868K | +6.9% |
| Stockholders' Equity | $5.8M | +1007.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.6M | -53.1% |
| Capital Expenditures | $29K | — |
| Investing Cash Flow | -$89K | — |
| Financing Cash Flow | $5.8M | +1833.0% |
| Free Cash Flow | -$1.6M | -56.0% |